Fibrosing Mediastinitis: Clinical Presentation, Therapeutic Outcomes, and Adaptive Immune Response

Published on Nov 1, 2011in Medicine1.552
· DOI :10.1097/MD.0B013E318237C8E6
Tobias Peikert29
Estimated H-index: 29
(Mayo Clinic),
Thomas V. Colby105
Estimated H-index: 105
+ 4 AuthorsUlrich Specks63
Estimated H-index: 63
Fibrosing mediastinitis (FM) is a rare disorder characterized by the invasive proliferation of fibrous tissue within the mediastinum. FM frequently results in the compression of vital mediastinal structures and has been associated with substantial morbidity and mortality. Its pathogenesis remains unknown. However, in North America most cases are thought to represent an immune-mediated hypersensitivity response to Histoplasma capsulatum infection. To characterize the clinical disease spectrum, natural disease pro- gression, responses to therapy, and overall survival, we retrospectively analyzed all 80 consecutive patients with a diagnosis of FM evaluated at Mayo Clinic, Rochester, MN, from 1998 to 2007. Furthermore, we characterized the adaptive immune response in 15 representative patients by immunohistochemistry. The majority of patients presented with nonspecific respiratory symp- toms due to the compression of mediastinal broncho-vascular structures. Chest radiographic imaging most frequently revealed localized, invasive, and frequently calcified right-sided mediastinal masses. Most patients had radiographic or serologic evidence of previous histoplasmosis. In contrast to earlier reports summarizing previously reported FM cases, the clinical course of our patients appeared to be more benign and less progressive. The overall survival was similar to that of age-matched controls. There were only 5 deaths, 2 of which were attributed to FM. These differences may reflect publication bias associated with the pref- erential reporting of more severely affected FM patients in the medical literature, as well as the more inclusive case definition used in our consecutive case series. Surgical and nonsurgical interventions effectively relieved symptoms caused by the compression of mediastinal vascular structures in these carefully selected patients. In contrast, antifungal and antiinflammatory agents appeared ineffective. Histologic examination and immunostaining revealed mixed inflammatory infiltrates consistent with a fibroin- flammatory tissue response in these histoplasmosis-associated FM cases. The immune cell infiltrates included large numbers of CD20-positive B lymphocytes. As B lymphocytes may contribute to the pathogenesis of the disease, therapeutic B-cell depletion should be investigated as a therapeutic strategy for FM. (Medicine 2011;90: 412Y423)
📖 Papers frequently viewed together
4 Authors (James E. Loyd, ..., Des Prez Rm)
145 Citations
119 Citations
3 Authors (Goodwin Ra, ..., Des Prez Rm)
163 Citations
#2Allison K. CabalkaH-Index: 30
Last. Donald J. Hagler (Mayo Clinic)H-Index: 72
view all 4 authors...
Objective. Fibrosing mediastinitis is a rare disorder characterized by an excessive fibrotic reaction in the mediastinum which can result in compromise of mediastinal structures. We sought to evaluate short- and midterm results of intravascular thoracic vessel stent placement for patients with fibrosing mediastinitis. Design. We reviewed all records of fibrosing mediastinitis patients who were referred for stent placement to treat mediastinal vascular compression over a 7-year period. Catheteriz...
16 CitationsSource
#1Zane Hammoud (HFH: Henry Ford Hospital)H-Index: 10
#2Anthony S. Rose (IU: Indiana University)H-Index: 5
Last. Kenneth A. Kesler (IU: Indiana University)H-Index: 34
view all 6 authors...
Background Histoplasmosis may result in a spectrum of complications that require thoracic surgical intervention. We reviewed our 17-year experience in the management of histoplasmosis to determine outcomes as well as gain insight into the distribution of complications requiring surgical intervention. Methods The hospital records of patients who underwent surgical treatment for complications related to histoplasmosis from 1991 to 2008 were reviewed. Based on the predominant presentation, patients...
18 CitationsSource
#1Morgan L. Brown (Mayo Clinic)H-Index: 24
#2Alex R. Cedeño (UPR: University of Puerto Rico)H-Index: 1
Last. Hartzell V. Schaff (Mayo Clinic)H-Index: 101
view all 5 authors...
Background Fibrosing mediastinitis is a rare disease characterized by an excessive fibrotic reaction in the mediastinum, which may entrap mediastinal structures including the pulmonary arteries. Our objectives were to assess the surgical strategies and outcomes of repair of pulmonary artery occlusion attributable to mediastinal fibrosis. Methods With approval from the Mayo Clinic Institutional Review Board, we identified all patients with fibrosing mediastinitis who underwent an operation for re...
15 CitationsSource
#1Robert Lafyatis (BU: Boston University)H-Index: 54
#2Eugene Y. Kissin (BU: Boston University)H-Index: 20
Last. Robert W. Simms (BU: Boston University)H-Index: 50
view all 8 authors...
Objective To determine the safety of rituximab, to provide preliminary data regarding the potential efficacy of rituximab, and to investigate the effects of rituximab on autoimmunity and fibrosis in patients with diffuse cutaneous systemic sclerosis (dcSSc). Methods Fifteen patients with dcSSc, all of whom experienced their first non–Raynaud's disease–associated disease manifestation within 18 months of trial entry, were recruited to receive 2 intravenous doses of rituximab (1,000 mg), administe...
285 CitationsSource
#1Ayumi Yoshizaki (Nagasaki University)H-Index: 24
#2Yohei Iwata (Nagasaki University)H-Index: 17
Last. Shinichi Sato (Nagasaki University)H-Index: 76
view all 12 authors...
Mice subcutaneously injected with bleomycin, in an experimental model of human systemic sclerosis, develop cutaneous and lung fibrosis with autoantibody production. CD19 is a general "rheostat" that defines signaling thresholds critical for humoral immune responses, autoimmunity, and cytokine production. To determine the role of CD19 in the bleomycin-induced systemic sclerosis model, we investigated the development of fibrosis and autoimmunity in CD19-deficient mice. Bleomycin-treated wild-type ...
231 CitationsSource
#1Rennae Thiessen (U of O: University of Ottawa)H-Index: 1
#2Fred MatzingerH-Index: 5
Last. Peter J. MacleodH-Index: 2
view all 5 authors...
Fibrosing mediastinitis is a rare benign condition, which can cause compression of the pulmonary or systemic vessels, tracheobronchial tree, coronary arteries or esophagus, leading to disabling clinical symptoms and even death. The case of a 26-year-old woman who presented with dyspnea is described. She was found to have 80% stenosis of the right pulmonary artery secondary to fibrosing mediastinitis. The stenosis was managed successfully with an endovascular Palmaz-Schatz stent, and the patient ...
16 CitationsSource
#1Dennis McGonagle (Calderdale Royal Hospital)H-Index: 75
#2Ai Lyn Tan (Calderdale Royal Hospital)H-Index: 33
Last. S. Thomas (Calderdale Royal Hospital)H-Index: 1
view all 7 authors...
103 CitationsSource
Sclerosing mediastinitis is not a common condition in the thoracic cavity and is difficult to cure. Several medications have been used; however, most of the cases do not achieve satisfactory results, and the most successful treatment is operative resection. We report the first case of IgG4-related sclerosing mediastinitis that showed IgG4-positive plasma cells infiltrated into the fibrous tissue and a high serum IgG4 level. The patient clearly showed remission of the symptoms after steroid thera...
57 CitationsSource
#1Amol TakalkarH-Index: 11
#2Gabriel L. BrunoH-Index: 2
Last. D Keith PayneH-Index: 1
view all 6 authors...
Abstract: Fibrosing mediastinitis is an uncommon benign disorder, and its pathogenesis and management remain unclear. Conventional imaging techniques (chest radiographs, CT, MRI) may suggest its diagnosis but are frequently nonspecific, and it frequently mimics a malignant process by presenting as a mediastinal mass without calcifications, encasing, and infiltrating adjacent mediastinal structures, and showing an overall aggressive behavior. The value of FDG PET imaging in this entity remains la...
16 CitationsSource
#1Kyung-Yung Lee (Konkuk University)H-Index: 9
#2Jeong Geun YiH-Index: 5
Last. Jin Sung KimH-Index: 15
view all 6 authors...
To our knowledge, no report exists of a posterior mediastinal thin band-like mass as a manifestation of fibrosing mediastinitis. A man showed right pleural effusion on chest radiograph. On CT, there was a band-like mass on thoracic prevertebral area. MRI demonstrated the enhancing longitudinal band-like mass all along the vertebrae on coronal and sagittal scans. It was hypermetabolic on PET–CT and there was another hot mass in the presacral area. Additional pelvic MRI showed presacral mass with ...
8 CitationsSource
Cited By69
Two children developed fibrosing mediastinitis following past tuberculosis disease. Both were microbiologically negative for tuberculosis at presentation. One was treated with steroids and supportive therapy, but developed active tuberculosis with complications. He ultimately succumbed to healthcare-associated infection. The other recovered with steroids, administered along with antituberculosis treatment.
#1John P. Welby (Mayo Clinic)H-Index: 5
#2Erin A. Fender (Mayo Clinic)H-Index: 9
Last. Erica M. Knavel-Koepsel (Mayo Clinic)
view all 6 authors...
#2Faisal AlsufyaniH-Index: 2
Last. Shiv PillaiH-Index: 50
view all 10 authors...
Although fibrotic disorders are frequently assumed to be linked to TH2 cells, quantitative tissue interrogation studies have rarely been performed to establish this link and certainly many fibrotic diseases do not fall within the type 2/allergic disease spectrum. We have previously linked two human autoimmune fibrotic diseases, IgG4-related disease and systemic sclerosis, to the clonal expansion and lesional accumulation of CD4+CTLs. In both these diseases TH2 cell accumulation was found to be s...
1 CitationsSource
#1Himanshu Deshwal (NYU: New York University)H-Index: 3
#2Subha Ghosh (Cleveland Clinic)H-Index: 6
Last. Atul C. Mehta (Cleveland Clinic)H-Index: 55
view all 6 authors...
Fibrosing mediastinitis (FM) is a rare disorder of inflammation and fibrosis involving the mediastinum. The formation of fibroinflammatory mass in the mediastinum can lead to obstruction of mediast...
#1Jeffrey C. Songster (UNMC: University of Nebraska Medical Center)H-Index: 1
#2Haiying Liu (UNMC: University of Nebraska Medical Center)H-Index: 1
Last. Rebecca A. Aron (UNMC: University of Nebraska Medical Center)H-Index: 1
view all 4 authors...
Pulmonary hypertension (PH) results from varied etiologies, leading to progressive symptoms and limiting physical activity and quality of life, with associated morbidity and mortality. External compression of the pulmonary artery (PA) is a rare cause of PH and may give the clinician cause to investigate compression of nearby structures. In this E-Challenge, the authors present a case of PA stenosis in a patient with prior histoplasmosis scheduled for left PA stenting. However, because the pulmon...
1 CitationsSource
#1Marwan M. Azar (Yale University)H-Index: 19
#2James L. Loyd (Vandy: Vanderbilt University)H-Index: 1
Last. Chadi A. Hage (IU: Indiana University)H-Index: 33
view all 5 authors...
Histoplasmosis is a global disease endemic to regions of all six inhabited continents. The areas of highest endemicity lie within the Mississippi and Ohio River Valleys of North America and parts of Central and South America. As a result of climate change and anthropogenic land utilization, the conditions suitable for Histoplasma capsulatum are changing, leading to a corresponding change in epidemiology. The clinical manifestations of histoplasmosis are protean, variably resembling other common ...
6 CitationsSource
#1Alexander Marx (Heidelberg University)H-Index: 52
The chapter on Nonneoplastic Thymic Lesions will cover the epidemiological, etiological and clinicopathological features of common thymic lesions (congenital and acquired cysts, including dysplasia); thymic follicular, rebound and “true” hyperplasia) as well as rare or recently described non-neoplastic thymic alterations that may form mass lesions and can mimic thymic neoplasms (“Lesa-like thymic hyperplasia”; “Cholesteroloma”; Fibrosing mediastinitis, including IgG4-related disease). Criteria c...
#2Matthieu ZellwegerH-Index: 13
Last. Michel GonzalezH-Index: 16
view all 3 authors...
#1Franklin A. Argueta (University of Texas Health Science Center at San Antonio)H-Index: 1
#2David Villafuerte (University of Texas Health Science Center at San Antonio)H-Index: 1
Last. Carlos S. Restrepo (University of Texas Health Science Center at San Antonio)H-Index: 22
view all 5 authors...
Abstract Fibrosing mediastinitis is a rare disorder characterized by the invasive proliferation of fibrous tissue within the mediastinum. This fibrosis can result in compression of intrathoracic structures including the pulmonary vasculature leading to clinical symptoms and complications like pulmonary hypertension. Here, we present two cases of young patients with fibrosing mediastinitis complicated by pulmonary artery stenosis requiring medical and endovascular management with excellent result...
1 CitationsSource